Your institution may have access to this item. Find your institution then sign in to continue.
Title
Movers & shakers.
Abstract
The article announces career developments involving executives in the scientific and chemistry industry in Great Britain as of April 1, 2023, including the resignation of Harry Brekelmans from his role as Projects and Technology Director at oil and gas company Shell, the appointment of Ripley Balou as non-executive director at antibody biotech RQ Bio, and the selection of John Bishop as chief technology officer (CTO) at Lyra Therapeutics.